APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urticaria Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Urticaria Drug Market Outlook and Growth Opportunities 2026

31 December 2025199 pages

Choose your research edition.

Industry ResearchUrticaria Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Urticaria Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Urticaria Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urticaria Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Urticaria Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Urticaria Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Urticaria Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Urticaria Drug market include Akorn, Amneal Pharmaceuticals, Genentech, Taro Pharmaceutical Industries Novartis AG, Xolair, Pfizer, Johnson and Johnson Services and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Urticaria Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Urticaria Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Urticaria Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Urticaria Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Urticaria Drug Segment by Company

Akorn

Amneal Pharmaceuticals

Genentech

Taro Pharmaceutical Industries Novartis AG

Xolair

Pfizer

Johnson and Johnson Services

Teva Pharmaceutical Industries

Urticaria Drug Segment by Type

Acute Urticaria

Chronic Urticaria

Urticaria Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Others

Urticaria Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Urticaria Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Urticaria Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Urticaria Drug significant trends, drivers, influence factors in global and regions.

6. To analyze Urticaria Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urticaria Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urticaria Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urticaria Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Urticaria Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urticaria Drug industry.

Chapter 3: Detailed analysis of Urticaria Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Urticaria Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Urticaria Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Urticaria Drug Industry Trends Table 2. Urticaria Drug Industry Drivers Table 3. Urticaria Drug Industry Opportunities and Challenges Table 4. Urticaria Drug Industry Restraints Table 5. Global Urticaria Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Urticaria Drug Revenue Share by Company (2021-2026) Table 7. Global Urticaria Drug Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Urticaria Drug Sales Volume Share by Company (2021-2026) Table 9. Global Urticaria Drug Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Urticaria Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global Urticaria Drug Key Company Manufacturing Base & Headquarters Table 12. Global Urticaria Drug Company, Product Type & Application Table 13. Global Urticaria Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Urticaria Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Acute Urticaria Table 18. Significant Companies of Chronic Urticaria Table 19. Global Urticaria Drug Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Urticaria Drug Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Urticaria Drug Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Urticaria Drug Sales Volume Share by Type (2021-2026) Table 23. Global Urticaria Drug Sales Volume Share by Type (2027-2032) Table 24. Global Urticaria Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Urticaria Drug Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Urticaria Drug Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Urticaria Drug Sales Value Share by Type (2021-2026) Table 28. Global Urticaria Drug Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Retail Pharmacies Table 30. Significant Companies of Online Pharmacies Table 31. Significant Companies of Hospital Pharmacies Table 32. Significant Companies of Others Table 33. Global Urticaria Drug Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Urticaria Drug Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Urticaria Drug Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Urticaria Drug Sales Volume Share by Application (2021-2026) Table 37. Global Urticaria Drug Sales Volume Share by Application (2027-2032) Table 38. Global Urticaria Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Urticaria Drug Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Urticaria Drug Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Urticaria Drug Sales Value Share by Application (2021-2026) Table 42. Global Urticaria Drug Sales Value Share by Application (2027-2032) Table 43. Global Urticaria Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Urticaria Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Urticaria Drug Sales Market Share by Region (2021-2026) Table 46. Global Urticaria Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Urticaria Drug Sales Market Share by Region (2027-2032) Table 48. Global Urticaria Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Urticaria Drug Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Urticaria Drug Sales Value Share by Region (2021-2026) Table 51. Global Urticaria Drug Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Urticaria Drug Sales Value Share by Region (2027-2032) Table 53. Global Urticaria Drug Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Urticaria Drug Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Urticaria Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Urticaria Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 58. Global Urticaria Drug Sales Market Share by Country (2021-2026) Table 59. Global Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 60. Global Urticaria Drug Sales Market Share by Country (2027-2032) Table 61. Global Urticaria Drug Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Urticaria Drug Sales Value Market Share by Country (2021-2026) Table 63. Global Urticaria Drug Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Urticaria Drug Sales Value Market Share by Country (2027-2032) Table 65. Akorn Company Information Table 66. Akorn Business Overview Table 67. Akorn Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Akorn Urticaria Drug Product Portfolio Table 69. Akorn Recent Development Table 70. Amneal Pharmaceuticals Company Information Table 71. Amneal Pharmaceuticals Business Overview Table 72. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Amneal Pharmaceuticals Urticaria Drug Product Portfolio Table 74. Amneal Pharmaceuticals Recent Development Table 75. Genentech Company Information Table 76. Genentech Business Overview Table 77. Genentech Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Genentech Urticaria Drug Product Portfolio Table 79. Genentech Recent Development Table 80. Taro Pharmaceutical Industries Novartis AG Company Information Table 81. Taro Pharmaceutical Industries Novartis AG Business Overview Table 82. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio Table 84. Taro Pharmaceutical Industries Novartis AG Recent Development Table 85. Xolair Company Information Table 86. Xolair Business Overview Table 87. Xolair Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Xolair Urticaria Drug Product Portfolio Table 89. Xolair Recent Development Table 90. Pfizer Company Information Table 91. Pfizer Business Overview Table 92. Pfizer Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Pfizer Urticaria Drug Product Portfolio Table 94. Pfizer Recent Development Table 95. Johnson and Johnson Services Company Information Table 96. Johnson and Johnson Services Business Overview Table 97. Johnson and Johnson Services Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Johnson and Johnson Services Urticaria Drug Product Portfolio Table 99. Johnson and Johnson Services Recent Development Table 100. Teva Pharmaceutical Industries Company Information Table 101. Teva Pharmaceutical Industries Business Overview Table 102. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Teva Pharmaceutical Industries Urticaria Drug Product Portfolio Table 104. Teva Pharmaceutical Industries Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Urticaria Drug Distributors List Table 108. Urticaria Drug Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Urticaria Drug Product Image Figure 2. Global Urticaria Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urticaria Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global Urticaria Drug Sales (2021-2032) & (K Units) Figure 5. Global Urticaria Drug Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Urticaria Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Acute Urticaria Image Figure 10. Chronic Urticaria Image Figure 11. Global Urticaria Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Urticaria Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Urticaria Drug Sales Volume Share by Type (2021-2032) Figure 14. Global Urticaria Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Urticaria Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Urticaria Drug Sales Value Share by Type (2021-2032) Figure 17. Retail Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Hospital Pharmacies Image Figure 20. Others Image Figure 21. Global Urticaria Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Urticaria Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Urticaria Drug Sales Volume Share by Application (2021-2032) Figure 24. Global Urticaria Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Urticaria Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Urticaria Drug Sales Value Share by Application (2021-2032) Figure 27. Global Urticaria Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Urticaria Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Urticaria Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Urticaria Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Urticaria Drug Sales Value (2021-2032) & (US$ Million) Figure 32. North America Urticaria Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Urticaria Drug Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Urticaria Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Urticaria Drug Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Urticaria Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Urticaria Drug Sales Value (2021-2032) & (US$ Million) Figure 38. South America Urticaria Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Urticaria Drug Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Urticaria Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Urticaria Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Urticaria Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Urticaria Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Urticaria Drug Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Urticaria Drug Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Acute Urticaria
  • Chronic Urticaria
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Others
Companies covered
  • Akorn
  • Amneal Pharmaceuticals
  • Genentech
  • Taro Pharmaceutical Industries Novartis AG
  • Xolair
  • Pfizer
  • Johnson and Johnson Services
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Urticaria Drug Sales Value (2021-2032)
  4. 1.2.2 Global Urticaria Drug Sales Volume (2021-2032)
  5. 1.2.3 Global Urticaria Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Urticaria Drug Market Dynamics
  1. 2.1 Urticaria Drug Industry Trends
  2. 2.2 Urticaria Drug Industry Drivers
  3. 2.3 Urticaria Drug Industry Opportunities and Challenges
  4. 2.4 Urticaria Drug Industry Restraints
3 Urticaria Drug Market by Company
  1. 3.1 Global Urticaria Drug Company Revenue Ranking in 2025
  2. 3.2 Global Urticaria Drug Revenue by Company (2021-2026)
  3. 3.3 Global Urticaria Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global Urticaria Drug Average Price by Company (2021-2026)
  5. 3.5 Global Urticaria Drug Company Ranking (2024-2026)
  6. 3.6 Global Urticaria Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global Urticaria Drug Company Product Type and Application
  8. 3.8 Global Urticaria Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Urticaria Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Urticaria Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Urticaria Drug Market by Type
  1. 4.1 Urticaria Drug Type Introduction
  2. 4.1.1 Acute Urticaria
  3. 4.1.2 Chronic Urticaria
  4. 4.2 Global Urticaria Drug Sales Volume by Type
  5. 4.2.1 Global Urticaria Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Urticaria Drug Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Urticaria Drug Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Urticaria Drug Sales Value by Type
  9. 4.3.1 Global Urticaria Drug Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Urticaria Drug Sales Value by Type (2021-2032)
  11. 4.3.3 Global Urticaria Drug Sales Value Share by Type (2021-2032)
5 Urticaria Drug Market by Application
  1. 5.1 Urticaria Drug Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Urticaria Drug Sales Volume by Application
  7. 5.2.1 Global Urticaria Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Urticaria Drug Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Urticaria Drug Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Urticaria Drug Sales Value by Application
  11. 5.3.1 Global Urticaria Drug Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Urticaria Drug Sales Value by Application (2021-2032)
  13. 5.3.3 Global Urticaria Drug Sales Value Share by Application (2021-2032)
6 Urticaria Drug Regional Sales and Value Analysis
  1. 6.1 Global Urticaria Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Urticaria Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Urticaria Drug Sales by Region: 2021-2026
  4. 6.2.2 Global Urticaria Drug Sales by Region (2027-2032)
  5. 6.3 Global Urticaria Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Urticaria Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global Urticaria Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global Urticaria Drug Sales Value by Region (2027-2032)
  9. 6.5 Global Urticaria Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Urticaria Drug Sales Value (2021-2032)
  12. 6.6.2 North America Urticaria Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Urticaria Drug Sales Value (2021-2032)
  15. 6.7.2 Europe Urticaria Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Urticaria Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Urticaria Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Urticaria Drug Sales Value (2021-2032)
  21. 6.9.2 South America Urticaria Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Urticaria Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Urticaria Drug Sales Value Share by Country, 2025 VS 2032
7 Urticaria Drug Country-level Sales and Value Analysis
  1. 7.1 Global Urticaria Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Urticaria Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Urticaria Drug Sales by Country (2021-2032)
  4. 7.3.1 Global Urticaria Drug Sales by Country (2021-2026)
  5. 7.3.2 Global Urticaria Drug Sales by Country (2027-2032)
  6. 7.4 Global Urticaria Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global Urticaria Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global Urticaria Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Urticaria Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Urticaria Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Urticaria Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Urticaria Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Urticaria Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Urticaria Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Urticaria Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Urticaria Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Urticaria Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Urticaria Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Urticaria Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Urticaria Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Urticaria Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Urticaria Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Urticaria Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Urticaria Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Urticaria Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Urticaria Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Urticaria Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Urticaria Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Urticaria Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Urticaria Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Urticaria Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Urticaria Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Urticaria Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Urticaria Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Urticaria Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Urticaria Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Urticaria Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Urticaria Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Urticaria Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Akorn Urticaria Drug Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Urticaria Drug Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Genentech
  14. 8.3.1 Genentech Company Information
  15. 8.3.2 Genentech Business Overview
  16. 8.3.3 Genentech Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Genentech Urticaria Drug Product Portfolio
  18. 8.3.5 Genentech Recent Developments
  19. 8.4 Taro Pharmaceutical Industries Novartis AG
  20. 8.4.1 Taro Pharmaceutical Industries Novartis AG Company Information
  21. 8.4.2 Taro Pharmaceutical Industries Novartis AG Business Overview
  22. 8.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio
  24. 8.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments
  25. 8.5 Xolair
  26. 8.5.1 Xolair Company Information
  27. 8.5.2 Xolair Business Overview
  28. 8.5.3 Xolair Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Xolair Urticaria Drug Product Portfolio
  30. 8.5.5 Xolair Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Urticaria Drug Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Johnson and Johnson Services
  38. 8.7.1 Johnson and Johnson Services Company Information
  39. 8.7.2 Johnson and Johnson Services Business Overview
  40. 8.7.3 Johnson and Johnson Services Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Johnson and Johnson Services Urticaria Drug Product Portfolio
  42. 8.7.5 Johnson and Johnson Services Recent Developments
  43. 8.8 Teva Pharmaceutical Industries
  44. 8.8.1 Teva Pharmaceutical Industries Company Information
  45. 8.8.2 Teva Pharmaceutical Industries Business Overview
  46. 8.8.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceutical Industries Urticaria Drug Product Portfolio
  48. 8.8.5 Teva Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Urticaria Drug Value Chain Analysis
  2. 9.1.1 Urticaria Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Urticaria Drug Sales Mode & Process
  6. 9.2 Urticaria Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Urticaria Drug Distributors
  9. 9.2.3 Urticaria Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst